Ignatiev V G, Zatravkin S N
N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia.
N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia,
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2023 Aug;31(Special Issue 1):711-724. doi: 10.32687/0869-866X-2023-31-s1-717-724.
This series of articles is devoted to an analysis of the drug safety policy of the Russian Federation. The second communication focuses on the history of strategy development and choice of tactics for pharmaceutical industry modernisation, the spectrum of interests of the concept-makers and the contradictions between the approaches. Based on journal publications and oral interviews, the authors traced the process of creating a regulatory agreement between political authorities and professional groups on power sharing and management delegation after the recognition of the pharmaceutical market as an object of state security.
本系列文章致力于对俄罗斯联邦的药品安全政策进行分析。第二篇文章聚焦于制药行业现代化战略发展的历史以及策略选择、概念制定者的利益范围和不同方法之间的矛盾。基于期刊出版物和口头访谈，作者追溯了在将制药市场确认为国家安全对象之后，政治当局与专业团体之间就权力分享和管理委托达成监管协议的过程。
